The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preimplantation Genetic Diagnosis Market Research Report 2025
Synopsis
Preimplantation Genetic Diagnosis (PGD) is a technique used for detecting genetic defects in embryos developed through in vitro fertilization (IVF) before pregnancy. PGD involves performing tests on embryos to determine genetic abnormality. PGD is an alternative to current post conception diagnostic procedures.
The global Preimplantation Genetic Diagnosis market was valued at US$ 493 million in 2023 and is anticipated to reach US$ 914 million by 2030, witnessing a CAGR of 8.9% during the forecast period 2024-2030.
North American market for Preimplantation Genetic Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preimplantation Genetic Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preimplantation Genetic Diagnosis in Fertility Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preimplantation Genetic Diagnosis include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Diagnosis.
Report Scope
The Preimplantation Genetic Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preimplantation Genetic Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preimplantation Genetic Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Coopersurgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Segment by Type
Genetic Diagnosis
Genetic Screening
Segment by Application
Fertility Clinics
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preimplantation Genetic Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Preimplantation Genetic Diagnosis (PGD) is a technique used for detecting genetic defects in embryos developed through in vitro fertilization (IVF) before pregnancy. PGD involves performing tests on embryos to determine genetic abnormality. PGD is an alternative to current post conception diagnostic procedures.
The global Preimplantation Genetic Diagnosis market was valued at US$ 493 million in 2023 and is anticipated to reach US$ 914 million by 2030, witnessing a CAGR of 8.9% during the forecast period 2024-2030.
North American market for Preimplantation Genetic Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preimplantation Genetic Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Preimplantation Genetic Diagnosis in Fertility Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Preimplantation Genetic Diagnosis include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories, Natera, Inc., Rubicon Genomics and Oxford Gene Technology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Diagnosis.
Report Scope
The Preimplantation Genetic Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preimplantation Genetic Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preimplantation Genetic Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Coopersurgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Segment by Type
Genetic Diagnosis
Genetic Screening
Segment by Application
Fertility Clinics
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preimplantation Genetic Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preimplantation Genetic Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genetic Diagnosis
1.2.3 Genetic Screening
1.3 Market by Application
1.3.1 Global Preimplantation Genetic Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Fertility Clinics
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Preimplantation Genetic Diagnosis Market Perspective (2019-2030)
2.2 Preimplantation Genetic Diagnosis Growth Trends by Region
2.2.1 Global Preimplantation Genetic Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Preimplantation Genetic Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Preimplantation Genetic Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Preimplantation Genetic Diagnosis Market Dynamics
2.3.1 Preimplantation Genetic Diagnosis Industry Trends
2.3.2 Preimplantation Genetic Diagnosis Market Drivers
2.3.3 Preimplantation Genetic Diagnosis Market Challenges
2.3.4 Preimplantation Genetic Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Preimplantation Genetic Diagnosis Players by Revenue
3.1.1 Global Top Preimplantation Genetic Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Preimplantation Genetic Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Preimplantation Genetic Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preimplantation Genetic Diagnosis Revenue
3.4 Global Preimplantation Genetic Diagnosis Market Concentration Ratio
3.4.1 Global Preimplantation Genetic Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Diagnosis Revenue in 2023
3.5 Preimplantation Genetic Diagnosis Key Players Head office and Area Served
3.6 Key Players Preimplantation Genetic Diagnosis Product Solution and Service
3.7 Date of Enter into Preimplantation Genetic Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Preimplantation Genetic Diagnosis Breakdown Data by Type
4.1 Global Preimplantation Genetic Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Preimplantation Genetic Diagnosis Forecasted Market Size by Type (2025-2030)
5 Preimplantation Genetic Diagnosis Breakdown Data by Application
5.1 Global Preimplantation Genetic Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Preimplantation Genetic Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Preimplantation Genetic Diagnosis Market Size (2019-2030)
6.2 North America Preimplantation Genetic Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Preimplantation Genetic Diagnosis Market Size by Country (2019-2024)
6.4 North America Preimplantation Genetic Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Preimplantation Genetic Diagnosis Market Size (2019-2030)
7.2 Europe Preimplantation Genetic Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Preimplantation Genetic Diagnosis Market Size by Country (2019-2024)
7.4 Europe Preimplantation Genetic Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Preimplantation Genetic Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Preimplantation Genetic Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Preimplantation Genetic Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Preimplantation Genetic Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Preimplantation Genetic Diagnosis Market Size (2019-2030)
9.2 Latin America Preimplantation Genetic Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Preimplantation Genetic Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Preimplantation Genetic Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Preimplantation Genetic Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Preimplantation Genetic Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Preimplantation Genetic Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Preimplantation Genetic Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina, Inc.
11.1.1 Illumina, Inc. Company Detail
11.1.2 Illumina, Inc. Business Overview
11.1.3 Illumina, Inc. Preimplantation Genetic Diagnosis Introduction
11.1.4 Illumina, Inc. Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.1.5 Illumina, Inc. Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Detail
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Detail
11.3.2 Agilent Technologies, Inc. Business Overview
11.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnosis Introduction
11.3.4 Agilent Technologies, Inc. Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.3.5 Agilent Technologies, Inc. Recent Development
11.4 Perkinelmer, Inc.
11.4.1 Perkinelmer, Inc. Company Detail
11.4.2 Perkinelmer, Inc. Business Overview
11.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnosis Introduction
11.4.4 Perkinelmer, Inc. Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.4.5 Perkinelmer, Inc. Recent Development
11.5 Coopersurgical
11.5.1 Coopersurgical Company Detail
11.5.2 Coopersurgical Business Overview
11.5.3 Coopersurgical Preimplantation Genetic Diagnosis Introduction
11.5.4 Coopersurgical Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.5.5 Coopersurgical Recent Development
11.6 ABBott Laboratories
11.6.1 ABBott Laboratories Company Detail
11.6.2 ABBott Laboratories Business Overview
11.6.3 ABBott Laboratories Preimplantation Genetic Diagnosis Introduction
11.6.4 ABBott Laboratories Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.6.5 ABBott Laboratories Recent Development
11.7 Natera, Inc.
11.7.1 Natera, Inc. Company Detail
11.7.2 Natera, Inc. Business Overview
11.7.3 Natera, Inc. Preimplantation Genetic Diagnosis Introduction
11.7.4 Natera, Inc. Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.7.5 Natera, Inc. Recent Development
11.8 Rubicon Genomics
11.8.1 Rubicon Genomics Company Detail
11.8.2 Rubicon Genomics Business Overview
11.8.3 Rubicon Genomics Preimplantation Genetic Diagnosis Introduction
11.8.4 Rubicon Genomics Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.8.5 Rubicon Genomics Recent Development
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Detail
11.9.2 Oxford Gene Technology Business Overview
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis Introduction
11.9.4 Oxford Gene Technology Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.9.5 Oxford Gene Technology Recent Development
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Detail
11.10.2 Yikon Genomics Business Overview
11.10.3 Yikon Genomics Preimplantation Genetic Diagnosis Introduction
11.10.4 Yikon Genomics Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.10.5 Yikon Genomics Recent Development
11.11 Scigene
11.11.1 Scigene Company Detail
11.11.2 Scigene Business Overview
11.11.3 Scigene Preimplantation Genetic Diagnosis Introduction
11.11.4 Scigene Revenue in Preimplantation Genetic Diagnosis Business (2019-2024)
11.11.5 Scigene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
